Dear Colleagues,

The updated version of the FINAL PROGRAM is published on the Conference website.
FINAL PROGRAM ON THE WEBSITE

Please find it here a printable version.
UPDATED FINAL PROGRAM TO PRINT

The Program and the most important information about the Conference will be published in the Program leaflet incl. QR code of the abstracts. This publication will be available upon Registration on-site.

Please note: the Organizers cannot assume liability for any changes in the program due to external or unforeseen circumstances.

REGISTRATION OFFICE OPENING HOURS
Friday, June 9, 2023: from 8:00-18:00
Saturday, June 10, 2023: 8:00-17:00
Sunday, June 11, 2023: 8:30-12:00

ONLINE REGISTRATION: the online registration site is open until Wednesday, June 7, 2023. After that date please register onsite. In the case of on-site registration, we may not provide you with all the materials and services available for early and regular registrants.
ONLINE REGISTRATION FORM

We are looking forward to welcoming you soon for this unique 150th anniversary!

ERS School Courses
http://www.ersnet.org/ers/default.aspx?id_fiche=75480
http://www.ersnet.org/ers/default.aspx?id_dossier=8896&id_langue=3

The conference will focus on the world wide epidemic of the Insulin Resistance Syndrome and its prevalence in special population groups, women, and children. The program will cover the various fields which are part of the Insulin Resistance Syndrome including cardiovascular disease, PCOS, sleep apnea, hypertension, dyslipidemia, glucose intolerance, and endothelial dysfunction and will look into the emerging field of insulin resistance in liver disease and the development of certain cancers.
For more information: http://www.insulinresistance.us/

The conference will focus on the world wide epidemic of the Insulin Resistance Syndrome and its prevalence in special population groups, women, and children. The program will cover the various fields which are part of the Insulin Resistance Syndrome including cardiovascular disease, PCOS, sleep apnea, hypertension, dyslipidemia, glucose intolerance, and endothelial dysfunction and will look into the emerging field of insulin resistance in liver disease and the development of certain cancers.
For more information: http://www.insulinresistance.us/